MENLO PARK, CA · CIK 0001540358
a16z
a16z Capital Management, L.L.C.
Portfolio value
$1.29B
| # | Issuer | Ticker | Weight | Value | Shares / Prin | QoQ |
|---|---|---|---|---|---|---|
| 1 | NAVAN INC Class A | NAVN |
28.9%
|
$373.6M | 28,218,676 SH | increased +4% |
| 2 | FIGMA INC Class A | FIG |
26.2%
|
$338.5M | 16,011,378 SH | reduced -1% |
| 3 | META PLATFORMS INC Class A | META |
9.4%
|
$121.6M | 212,531 SH | unchanged |
| 4 | REVOLUTION MEDICINES INC | RVMD |
6.9%
|
$89.6M | 921,099 SH | unchanged |
| 5 | NAUTILUS BIOTECHNOLOGY INC | NAUT |
5.3%
|
$68.5M | 17,653,917 SH | unchanged |
| 6 | BLOCK INC Class A | XYZ |
4.7%
|
$61.2M | 1,016,697 SH | unchanged |
| 7 | BIOAGE LABS INC | BIOA |
4.4%
|
$56.5M | 3,233,170 SH | unchanged |
| 8 | MAZE THERAPEUTICS INC | MAZE |
3.9%
|
$50.8M | 1,702,225 SH | unchanged |
| 9 | ERASCA INC | ERAS |
3.6%
|
$46.3M | 2,862,500 SH | unchanged |
| 10 | DAMORA THERAPEUTICS INC | DMRA |
2.5%
|
$32.0M | 1,236,157 SH | new |
| 11 | OMADA HEALTH INC | OMDA |
2.2%
|
$29.0M | 2,307,284 SH | reduced -33% |
| 12 | CAMP4 THERAPEUTICS CORP | CAMP |
0.7%
|
$9.4M | 2,125,339 SH | unchanged |
| 13 | AKTIS ONCOLOGY INC | AKTS |
0.6%
|
$7.4M | 415,000 SH | new |
| 14 | BITGO HOLDINGS INC Class A | BTGO |
0.4%
|
$5.5M | 666,356 SH | new |
| 15 | GINKGO BIOWORKS HOLDINGS INC Class A | DNA |
0.1%
|
$666K | 108,568 SH | unchanged |
| 16 | IP STRATEGY HOLDINGS INC | IPST |
0.0%
|
$22K | 82,740 SH | new |
New this quarter
| Issuer | Ticker | Value | Shares |
|---|---|---|---|
| DAMORA THERAPEUTICS INC | DMRA | $32.0M | 1,236,157 |
| AKTIS ONCOLOGY INC | AKTS | $7.4M | 415,000 |
| BITGO HOLDINGS INC | BTGO | $5.5M | 666,356 |
| IP STRATEGY HOLDINGS INC | IPST | $22K | 82,740 |
Exited this quarter
| Issuer | Ticker | Prior value | Prior shares |
|---|---|---|---|
| HERITAGE COMM CORP | XHC | $129K | 82,740 |